Per the terms of the agreement, Novavax will receive an upfront payment of $30 million from Pfizer and is eligible to earn up to $500 million in potential development and commercial milestone payments ...
Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...
Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...
Coming into the season, Texas was the favorite to win the National Championship, earning the top ranking in the AP Poll. Finishing the season 10-3 and missing the College Football Playoff was a ...
SAN RAMON, Calif.--(BUSINESS WIRE)--Armanino, one of the 20 largest accounting and business consulting firms in the U.S., today announced that the team from Sales Tax Defense, a leading firm ...
Chip startup d-Matrix Inc. today disclosed that it has raised $275 million in funding to support its commercialization efforts. The Series C round was led by Bullhound Capital, Triatomic Capital and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results